Cannabis Rescheduling Is Not the Story People Think It Is
Acting AG Todd Blanche’s order finally moves cannabis to Schedule III. But as the headlines celebrate a policy win, the clinical work of precision medicine is only just starting.
April 23, 2026
Over the last 24 hours, my inbox has been a flood of “we did it” messages.
The news is indeed historic. This morning, Acting Attorney General Todd Blanche signed the directive reclassifying state-licensed medical cannabis as a Schedule III substance. For the first time since 1970, the federal government has officially retreated from the stance that cannabis has “no accepted medical use.”
But as I look across the coverage from the Wall Street Journal, ABC News, and the Associated Press, I see a narrative that is dangerously simplified. The media is painting this as a “softening” of the rules—a signal that cannabis is “less dangerous.”
From where I sit, in the exam room with patients navigating complex chronic conditions, today isn’t about cannabis getting “safer.” It’s about cannabis finally being allowed to enter the framework of real medicine.
Beyond the Headlines: What the Media is Compressing
If you read the Wall Street Journal, the story is economic—the removal of the 280…
